<PAGE> 1
As filed with the Securities and Exchange Commission on August 6, 1996
Registration No. 333-3616
================================================================================
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
--------------------------------
POST-EFFECTIVE AMENDMENT NO. 1
to
FORM S-1
REGISTRATION STATEMENT
Under
THE SECURITIES ACT OF 1933
--------------------------------
CARDIAC PATHWAYS CORPORATION
(Exact name of issuer as specified in its charter)
California (prior to reincorporation) 77-0278793
Delaware (after reincorporation) (I.R.S. Employer Identification No.)
(State or other jurisdiction
of incorporation or organization)
995 Benecia Avenue
Sunnyvale, California 94086
(408) 737-0505
(Address and telephone number of principal executive offices)
--------------------------------
David W. Gryska
Vice President, Finance and
Chief Financial Officer
Cardiac Pathways Corporation
995 Benecia Avenue
Sunnyvale, California 94086
(408) 737-0505
(Name, address and telephone number of agent for service)
================================================================================
<PAGE> 2
The Registrant hereby withdraws from registration 375,000 shares of
Common Stock, .001 par value, registered to cover an over-allotment option
granted to the Underwriters. The over-allotment option was not exercised and has
expired with respect to the unexercised shares. The Registration Statement is
hereby amended, as appropriate, to reflect the expiration of such option.
-2-
<PAGE> 3
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the
Registrant, Cardiac Pathways Corporation, has duly caused this Post-Effective
Amendment No. 1 to Registration Statement on Form S-1 to be signed on its behalf
by the undersigned, thereunto duly authorized, in the City of Sunnyvale, State
of California, on this 6th day of August, 1996.
CARDIAC PATHWAYS CORPORATION
By /s/ WILLIAM N. STARLING
--------------------------------------
(William N. Starling)
President, Chief Executive Officer and
Chairman of the Board of Directors
Pursuant to the requirements of the Securities Act of 1933, this
Post-Effective Amendment to Registration Statement has been signed by the
following persons in the capacities and on the dates indicated:
<TABLE>
<CAPTION>
SIGNATURE TITLE DATE
--------- ----- ----
<S> <C> <C>
/s/ WILLIAM N. STARLING President, Chief Executive Officer and August 6, 1996
- ------------------------------------------- Chairman of the Board of Directors (Principal
(William N. Starling) Executive Officer)
DAVID W. GRYSKA* Vice President, Finance and Chief Financial August 6, 1996
- ------------------------------------------- Officer (Principal Financial and Accounting
(David W. Gryska) Officer)
LAWRENCE G. MOHR, JR.* Director August 6, 1996
- -------------------------------------------
(Lawrence G. Mohr, Jr.)
Director
- -------------------------------------------
(Michael L. Eagle)
JOSEPH P. ILVENTO, M.D.* Director August 6, 1996
- -------------------------------------------
(Joseph P. Ilvento, M.D.)
THOMAS J. FOGARTY, M.D.* Director August 6, 1996
- -------------------------------------------
(Thomas J. Fogarty, M.D.)
ANNETTE CAMPBELL-WHITE* Director August 6, 1996
- -------------------------------------------
(Annette Campbell-White)
*By: /s/ WILLIAM N. STARLING
- -------------------------------------------
(Attorney-In-Fact)
</TABLE>
